Prof.  

Wendy Cantrell


Presentations

Efficacy and Safety of Tildrakizumab 100 mg for Plaque Psoriasis in Patients Randomized to Treatment Continuation vs Treatment Withdrawal with Retreatment upon Relapse in reSURFACE1 09 October 2019 00:00 - 00:00

Abstracts

Efficacy and Safety of Tildrakizumab 100 mg for Plaque Psoriasis in Patients Randomized to Treatment Continuation vs Treatment Withdrawal with Retreatment upon Relapse in reSURFACE1 Psoriasis More